DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,509,000 | -15.2% | 5,955 | -1.9% | 0.49% | -1.4% |
| Q1 2022 | $1,780,000 | -10.5% | 6,069 | +0.4% | 0.50% | -8.3% |
| Q4 2021 | $1,988,000 | +8.5% | 6,042 | +0.3% | 0.54% | -0.7% |
| Q3 2021 | $1,833,000 | +12.5% | 6,021 | -0.8% | 0.54% | +11.9% |
| Q2 2021 | $1,629,000 | +19.2% | 6,069 | -0.0% | 0.49% | +13.0% |
| Q1 2021 | $1,367,000 | +12.0% | 6,070 | +10.5% | 0.43% | 0.0% |
| Q4 2020 | $1,221,000 | -3.6% | 5,495 | -6.5% | 0.43% | -12.4% |
| Q3 2020 | $1,266,000 | +23.3% | 5,878 | +1.2% | 0.49% | +13.4% |
| Q2 2020 | $1,027,000 | +35.1% | 5,811 | +5.8% | 0.43% | +12.1% |
| Q1 2020 | $760,000 | -9.8% | 5,490 | +0.0% | 0.39% | +24.8% |
| Q4 2019 | $843,000 | +9.3% | 5,488 | +2.8% | 0.31% | +2.6% |
| Q3 2019 | $771,000 | +0.3% | 5,337 | -0.8% | 0.30% | +0.7% |
| Q2 2019 | $769,000 | +10.5% | 5,382 | +2.1% | 0.30% | +9.9% |
| Q1 2019 | $696,000 | +25.2% | 5,271 | -2.2% | 0.27% | +9.2% |
| Q4 2018 | $556,000 | -0.4% | 5,392 | +5.0% | 0.25% | +17.9% |
| Q3 2018 | $558,000 | +31.6% | 5,133 | +19.4% | 0.21% | +22.5% |
| Q2 2018 | $424,000 | +14.0% | 4,298 | +13.1% | 0.17% | +16.9% |
| Q1 2018 | $372,000 | +12.0% | 3,799 | +6.3% | 0.15% | +22.3% |
| Q4 2017 | $332,000 | +9.6% | 3,574 | +1.0% | 0.12% | +5.2% |
| Q3 2017 | $303,000 | +7.4% | 3,538 | +5.8% | 0.12% | -10.9% |
| Q2 2017 | $282,000 | +1.4% | 3,344 | +2.9% | 0.13% | +0.8% |
| Q1 2017 | $278,000 | -11.7% | 3,251 | -19.5% | 0.13% | -13.5% |
| Q4 2016 | $315,000 | -4.3% | 4,041 | -3.7% | 0.15% | -0.7% |
| Q3 2016 | $329,000 | -20.5% | 4,195 | +2.2% | 0.15% | -27.0% |
| Q2 2016 | $414,000 | +11.3% | 4,103 | +4.5% | 0.20% | +6.2% |
| Q1 2016 | $372,000 | +10.1% | 3,926 | +7.8% | 0.19% | +6.1% |
| Q4 2015 | $338,000 | +11.9% | 3,642 | +2.8% | 0.18% | +4.0% |
| Q3 2015 | $302,000 | +15.3% | 3,542 | +15.7% | 0.17% | +2.4% |
| Q2 2015 | $262,000 | +8.3% | 3,061 | +7.3% | 0.17% | +25.9% |
| Q1 2015 | $242,000 | +8.0% | 2,852 | +9.2% | 0.14% | +12.5% |
| Q4 2014 | $224,000 | – | 2,611 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |